Wire · opportunities
Washington House passes FDA bill to move medicine testing beyond animals
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 July 2026 · Fusion42 review
The US House passed the FDA Modernisation Act 3.0, directing the FDA to update regulations to permit non-animal testing methods for drug development, building on the 2022 Act that removed the mandatory animal testing requirement. The bill now heads to the Senate and could reshape drug development timelines, costs, and safety testing accuracy.
This Wire brief sits within Fusion42's coverage of Digital Health, and 2 sources have reported it between 22 Jul 2026 and 27 Jul 2026.
◆ ◆ The Wire takeaway
If you build organ-on-chip, microphysiology, AI-driven toxicology, or any non-animal testing platform, the FDA just made your regulatory path shorter and your market larger — the agency will now actively rewrite guidance to allow what it already permits, turning your alternative from niche into standard.
◆ Coverage
2 sources · first reported 22 Jul 2026 · latest 27 Jul 2026
◆ Related on Wire
◆ Topics